SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(B) OR (G) OF THE
SECURITIES EXCHANGE ACT OF 1934
U.S. LABORATORIES INC.
(Exact Name of Registrant as Specified in Its Charter)
Delaware 33-0586167
(State of Incorporation or Organization) (I.R.S. Employer Identification Number)
7895 Convoy Street
Suite 18 92111
San Diego, California (Zip Code)
(Address of Principal Executive Offices)
If this form relates to the registration If this form relates to the
of a class of securities pursuant to registration of a class of
section 12(b)of the Exchange Act and securities pursuant to Section
is effective pursuant to General 12(g) of the Exchange Act and is
Instruction A. (c), please check effective pursuant to General
the following box. |_| instruction A.(d), please check
the following box. |X|
Securities Act registration statement file number to which this form relates:
333-66173. (if applicable)
Securities to be registered pursuant to Section 12(b) of the Act:
Title of Each Class to be so Registered Name of Each Exchange on Which
Each Class is to be Registered
Not Applicable Not Applicable
-1-
<PAGE>
Securities to be registered pursuant to Section 12(g) of the Act:
Common Stock, $0.01 par value
(Title of Class)
Redeemable Common Stock Purchase Warrant
(Title of Class)
Item 1. Description of Registrant's Securities to be Registered.
Incorporated herein by reference to the Description of Capital Stock section of
the Registrant's Amendment No. 2 to its Registration Statement on Form SB-2
(File No. 333-66173).
Item 2. Exhibits
- ------
Exhibit
Number Description
--------- --------------
*3.1 Amended and Restated Certificate of Incorporation of the
Registrant.
*3.2 Bylaws of the Registrant.
**4.1 Warrant Agreement, including Form of Warrant
**4.4 Specimen certificate representing shares of Common Stock
of the Registrant.
*Incorporated herein by reference to the exhibits of the same number in the
Registrant's Registration Statement on Form SB-2 filed with the Securities and
Exchange Commission on October 29, 1998.
**Incorporated herein by reference to the exhibits of the same number in the
Registrant's Amendment No. 2 to its Registration Statement on Form SB-2 filed
with the Securities and Exchange Commission on January 28, 1999.
-2-
<PAGE>
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the registrant has duly caused the registration statement to be signed
on its behalf by the undersigned, thereto duly authorized.
U.S. LABORATORIES INC.
Date: February 2, 1999 By: /s/ James D. Wait
----------------------------------
James D. Wait
Chief Financial Officer
-3-
